Log in

OTCMKTS:TRGMTargeted Medical Pharma Stock Price, Forecast & News

0.00 (0.00 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Average Volume27,193 shs
Market Capitalization$294,700.00
P/E RatioN/A
Dividend YieldN/A
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.68 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:TRGM



Sales & Book Value

Annual SalesN/A



Market Cap$294,700.00
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRGM News and Ratings via Email

Sign-up to receive the latest news and ratings for TRGM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Targeted Medical Pharma (OTCMKTS:TRGM) Frequently Asked Questions

How has Targeted Medical Pharma's stock price been impacted by COVID-19?

Targeted Medical Pharma's stock was trading at $0.0094 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRGM stock has increased by 6.4% and is now trading at $0.01.
View which stocks have been most impacted by COVID-19

Has Targeted Medical Pharma been receiving favorable news coverage?

News headlines about TRGM stock have been trending positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Targeted Medical Pharma earned a news sentiment score of 2.4 on InfoTrie's scale. They also gave news stories about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Targeted Medical Pharma

Who are some of Targeted Medical Pharma's key competitors?

What other stocks do shareholders of Targeted Medical Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Targeted Medical Pharma investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Biocept (BIOC), ArQule (ARQL), Arena Pharmaceuticals (ARNA), ARI Network Services (ARIS), Aoxing Pharmaceutical (AOXG), Aeolus Pharmaceuticals (AOLS), Amarin (AMRN) and American International Group (AIG).

Who are Targeted Medical Pharma's key executives?

Targeted Medical Pharma's management team includes the following people:
  • Mr. Douglas P. Gintz, Chief Marketing & Technology Officer (Age 52)
  • Mr. Kim Giffoni, Exec. VP of Foreign Sales (Age 67)
  • Marcus Charuvastra, MD & Director

What is Targeted Medical Pharma's stock symbol?

Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."

How do I buy shares of Targeted Medical Pharma?

Shares of TRGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Targeted Medical Pharma's stock price today?

One share of TRGM stock can currently be purchased for approximately $0.01.

How big of a company is Targeted Medical Pharma?

Targeted Medical Pharma has a market capitalization of $294,700.00. Targeted Medical Pharma employs 30 workers across the globe.

What is Targeted Medical Pharma's official website?

The official website for Targeted Medical Pharma is www.targetedmedicalpharma.com.

How can I contact Targeted Medical Pharma?

Targeted Medical Pharma's mailing address is 2980 BEVERLY GLEN CIRCLE SUITE 301, LOS ANGELES CA, 90077. The specialty pharmaceutical company can be reached via phone at 310-474-9809 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.